Azerbaijan Post-Market File Consistency: Article 1.5 and the 7-Working-Day Filing Rule

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The core post-market obligation is consistency maintenance. Article 1.5 provides that where any change occurs in the information reflected in the documents listed in Parts 3 and 4 for a registered product, that change must undergo State registration. The second sentence of Article 7.8 provides that the certificate holder must file the application for State registration of a change to the registration documents of a device with the Ministry of Health within 7 working days.

There are three public sources to compare consistency against: the 7 Register fields (Article 10.4), the certificate fields (Annexes 5 and 6), and the electronically uploaded packaging description and instructions for use (Articles 10.5 and 9.2). A mismatch at any of these points against the physical product can trigger the formal warning of Article 11.1.3 and, if unheeded, the suspension of Article 11.1.3.

In practice, consistency is not only a design-engineering matter. It covers every public data point: the fields printed on the certificate, the fields published in the Register, the packaging description uploaded electronically, the instructions-for-use PDF downloadable from the AEC website, and the 11 dossier items that support them all.

2. Legal basis

  • Resolution No. 345 of the Cabinet of Ministers of the Republic of Azerbaijan of 18 July 2024 approving the Rules for the State Registration of Medicines, Pharmaceutical Substances and Medical Devices, Their Entry in the State Register and the Maintenance of the State Register (in force from 19 July 2024; Xalq qəzeti No. 151 of 20 July 2024; Legislative Collection 2024, No. 7, Article 906; repealing Resolution No. 108 of 13 July 2007 with effect from 20 July 2024): Article 1.5 (changes must undergo State registration), second sentence of Article 7.8 (filing within 7 working days), Article 7.2 (changes to certificate information lead to a new certificate), Article 7.7 (changes not affecting certificate information proceed without a new certificate), Article 10.4 (the 7 Register fields), Article 10.5 (electronic upload of the certificate, the packaging description and the instructions for use), Article 9.2 (confirmed instructions for use published on the AEC website), Article 11.1.3 (suspension for non-compliant packaging and labelling with an unheeded warning), Article 13.1 (confidentiality).
  • Law of the Republic of Azerbaijan on Medicines (No. 208-IIIQ, adopted 22 December 2006, in force 28 February 2007, Legislative Collection 2007, No. 2, Article 70), as amended by Law No. 979-VIQD of 14 July 2023 (adding Articles 1-1 and 9-1 as new provisions, Legislative Collection 2023, No. 8, Article 1127): Article 6.10 (state fee payable for change registration), Article 6.16 (payment within 5 working days), Article 6.12 (residual sale of products already in circulation during validity).
  • Administrative Procedures Code of the Republic of Azerbaijan: Article 31 (acceptance and registration of applications), Article 52 (correction of deficiencies).

3. Expert insights

Insight one: what consistency maintenance protects is information, not the product. The trigger of Article 1.5 is a change in the information reflected in the documents. Post-market vigilance must therefore cover not only design changes but also the certificate and Register fields, the uploaded packaging description, the published instructions-for-use PDF, and the 11 dossier items behind them. Turning the 11 dossier items into an annual review sheet is the recommended baseline.

Insight two: 7 working days is a hard deadline, counted from the moment the change occurs. The second sentence of Article 7.8 uses an obligatory formulation — must file within 7 working days. This means the company must be able to perceive the moment a change occurs, including changes on the manufacturer side (certificate changes, name changes, quality system changes) and on its own side (packaging changes, label changes). A contractual change-notification obligation on the manufacturer side is the first line of defence for this provision.

Insight three: Article 7.7 gives changes that do not touch certificate fields a low-cost route. Where a change does not alter the information contained in the Annex 5 or Annex 6 certificate, State registration proceeds without issuing a new certificate. This route changes no public fields and requires no reissue — the cheapest change channel. The decision tool is the field list of Annex 5.

Insight four: Article 11.1.3 makes packaging and labelling consistency a warnable matter. Non-compliant packaging or labelling plus an unheeded formal AEC warning constitutes a suspension ground. Combined with Article 1.5, the sequence is stark: a packaging change not declared breaches Article 1.5; failure to remediate after a warning triggers Article 11.1.3. Packaging redesign is the most overlooked and the heaviest consequence-bearing consistency item.

Insight five: change registration does not reset the 5-year cycle, so annual self-checks must run in step with the renewal ledger. The final sentence of Article 7.2 provides that the validity of a new certificate issued through change registration is bounded by the previous certificate. Changes discovered in an annual self-check therefore never extend certificate validity, however quickly they are processed; renewal must still be filed at least 7 working days before expiry under the first sentence of Article 7.8. The two ledgers — the change ledger and the renewal ledger — should be viewed in one dashboard.

4. Practical recommendations

  1. Turn the 11 dossier items of Article 4.2 into an annual review sheet with a named owner and review points for each item.
  2. Write a change-notification obligation into manufacturer cooperation agreements (certificate changes, name changes, system changes and material changes to be notified within a fixed number of days).
  3. Complete the filing within 7 working days of a change, working back internally to a 5-working-day target.
  4. Use the Annex 5 field list to choose the change route: changes touching certificate fields follow Article 7.2, others follow Article 7.7.
  5. Treat packaging and label redesign as the highest priority item: file first, then ship.
  6. Manage the change ledger and the renewal ledger in a single combined view so that change processing never delays the renewal window.

5. Verification checklist

  • □ An annual review sheet covering the 11 dossier items has been built with named owners.
  • □ The manufacturer cooperation agreement states the change-notification obligation and its deadline.
  • □ Change filings follow the 7-working-day deadline (internal target 5 working days).
  • □ A change-route decision process based on the Annex 5 field list is in place.
  • □ Packaging and label redesign is designated the highest-priority item.
  • □ The change ledger and the renewal ledger are managed in a combined view.
  • Article 35 — Changes also require State registration: Article 1.5 and the 7 working days: https://www.grzanglobal.com/azerbaijan-medical-device-registration/changes-require-state-registration/
  • Article 36 — The two change routes: with and without a new certificate: https://www.grzanglobal.com/azerbaijan-medical-device-registration/two-routes-for-changes/
  • Article 41 — The State Register: the seven data fields for devices: https://www.grzanglobal.com/azerbaijan-medical-device-registration/state-register-seven-data-fields/

Regulatory information verified as of October 30, 2026.

GRZAN supports manufacturers and authorised representatives preparing registration dossiers and post-market compliance documentation for the Azerbaijan market, from annual dossier review sheets and change-route decisions to combined change and renewal ledgers. For tailored assistance with your Azerbaijan medical device documentation, contact us at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail